CSIR Appointed as a Key Player in African Biomanufacturing Initiative
In an exciting development for the African scientific community, the Council for Scientific and Industrial Research (CSIR) has officially been designated as one of four Regional Capability and Capacity Network (RCCN) Secretariats by the Africa Centres for Disease Control and Prevention (Africa CDC). This noteworthy announcement was made during the 2nd Vaccine and Other Health Products Manufacturing Forum held in Cairo, Egypt, from February 4 to 7, 2025, a significant gathering aimed at enhancing vaccine manufacturing capabilities across the continent.
The overarching aim of the RCCNs is to boost biomanufacturing workforce training and development. This will encompass a wide variety of programs, including hands-on training, scholarships, vocational courses, internships, fellowships, and funding for necessary training infrastructure. The initiative is designed to nurture a new generation of skilled professionals who are prepared to meet Africa’s healthcare challenges head-on.
Dr. Santosh Ramchuran, CSIR’s Chief Researcher and Project Lead for the Southern African RCCN, expressed his enthusiasm for the role. “At the CSIR, we are delighted to lead the Southern African RCCN in collaboration with our esteemed partners such as Afrigen, Biovac, UVU Bio, the South African Medical Research Council, and various higher education institutions,” he stated. This collaborative effort highlights the vital partnerships needed to foster expertise in biomanufacturing across Southern Africa.
Engagements are currently in motion to include other southern African nations in this vital initiative. According to Dr. Ramchuran, it represents a shared vision among countries seeking to develop skills and expertise in biomanufacturing. The Southern African RCCN will work hand-in-hand with three other designated centers across the continent, including the Institut Pasteur du Maroc in North Africa, the Egyptian Authority for Unified Procurement, Rwanda’s Africa Biomanufacturing Institute in East Africa, and the Institut Pasteur de Dakar in Senegal representing West Africa.
Dr. Ramchuran expressed his gratitude, saying, “It is truly an honour to be selected as an RCCN Secretariat. We would like to express our heartfelt thanks to Dr. Glaudina Loots from the Department of Science, Technology and Innovation for her guidance and support during our application process.”
Looking ahead, the next steps involve the signing of a memorandum of understanding with Africa CDC and the RCCNs, which will pave the way for the implementation of essential training programs. This is part of a larger strategy aimed at increasing vaccine manufacturing capacity in Africa, with an ambitious target of producing over 60% of the continent’s total vaccine doses by 2040.
As African nations unite in their quest for self-sufficiency in health product manufacturing, initiatives like these not only showcase the continent’s commitment to innovation in healthcare but also reinforce the idea that Africa is poised for a significant leap forward in biomanufacturing.
#SouthAfrica #Egypt #Biomanufacturing #HealthCare #Innovation #Africa #WorldNews #Lifestyle
